The Murine Breeding and Molecular Genetics Core, located at the Bedford VAMC, supports the scientific research program at Boston University School of Medicine. The murine Breeding facility currently maintains a transgenic model of mice that under express apolipoprotein E (APOE) 2) Mice that express human variants of APOE 3) mice that over express or under express superoxide dismutase (SOD) 4) Calreticulin knockout mice. This comprehensive breeding facility will provide a unique resource for investigators by breeding specific mouse strains to produce mice required by the various investigators. Each of the models is relevant to different aspects of neurodegenerations and the development of therapeutic agents. The overall goal of the Mouse Breeding portion of the core is to maintain murine animal colonies and provider mice and/or animal tissues specimens for the purpose of experimental scientific research into various aspects of the pathological processes associated with AD. The Core will develop and maintain an information resource on animal experiments. This will include a database of information on the animal models (transgenic and knockout) and their potential use to researchers. The Core will be constantly working to bring in new transgenic mice, knockout mice and/or inducible transgenic systems to further research in AD. The Molecular Genetics portion of the core will provide support for the genetic studies conducted by investigators associated with the BU ADC and associated investigators. The Core will be responsible for the isolation of DNA from blood and/or buccal swabs obtained from patients followed by the Clinical Core. The DNA and serum will then be stored for distribution to investigators. The Core will also be responsible for the ApoE genotyping of patients followed by the Clinical Core and the genotyping of the transgenic animals being bred by this core. The Molecular Genetics portion of the core will also provide technical support for investigators from the BU, ADC, BUSM, as well as other Alzheimer's researchers. The Murine Breeding and Molecular Genetics Core will provide BU ADC associated investigators, as well as other AD researchers a centralized resource, providing ready access to well characterized murine models and human DNA samples for investigators molecular and genetic mechanisms associated with neurological diseases. This core will also help foster scientific collaboration between investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG013846-07
Application #
6631196
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2002-08-15
Project End
2003-06-30
Budget Start
Budget End
Support Year
7
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Boston University
Department
Type
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Alosco, Michael L; Tripodis, Yorghos; Fritts, Nathan G et al. (2018) Cerebrospinal fluid tau, A?, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration. Alzheimers Dement 14:1159-1170
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Guan, Yue; Roter, Debra L; Wolff, Jennifer L et al. (2018) The impact of genetic counselors' use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer's disease. Patient Educ Couns 101:817-823
Li, Jinlei; Ogrodnik, Matthew; Devine, Sherral et al. (2018) Practical risk score for 5-, 10-, and 20-year prediction of dementia in elderly persons: Framingham Heart Study. Alzheimers Dement 14:35-42
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487

Showing the most recent 10 out of 791 publications